The prevalence of some neurodevelopmental disorders has increased in recent years. Although these disorders can have a genetic component, several external factors also play a role in the development of neurodevelopmental diseases. Eurofins Clinical Diagnostics laboratories offer genetic testing to look for mutations, methylations and other alterations in a genome. When the symptomatology is not clear, Whole Exome Sequencing (WES) is recommended.

Chronic headache and fibromyalgia can occur simultaneously for many patients. Diagnosis of these diseases is not easy, and some patients suffer from not having a timely diagnosis. Clinical genetic testing offered at Eurofins Clinical Diagnostics laboratories can facilitate easier and faster diagnosis. Patients that require medication to treat depression can suffer side-effects that make treatment adherence a challenge. Dosage personalisation based on the genetic profile of each patient minimises side effects and improves treatment outcomes.

Difficulties in diagnosing Alzheimer's disease means that early treatment is not always possible. For those predisposed to suffer the disease, genetic testing can allow for engagement with treatment at an early stage which can slow down disease progression. Parkinson’s disease is usually only diagnosed when motor symptoms appear. At that stage the disease is already quite advanced. Eurofins Clinical Diagnostics laboratories carry out testing to identify mutations responsible for Amyotrophic Lateral Sclerosis (ALS) and Huntington’s disease, this testing is crucial in supporting diagnosis.